So now Johnson and Johnson follows on from #4 NOVAVAX.
Its a viral vector vaccine, decent tech and lower efficacy at 66% for mild disease, 72% for moderate disease, and 85% for severe disease.
Still lots to unpack but its a SINGLE SHOT, does not require FREEZING, and can get distributed...